# A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

> **NCT03878446** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 62 (actual)

## Conditions studied

- Short Stature Children Born Small for Gestational Age (SGA)

## Interventions

- **DRUG:** Somapacitan
- **DRUG:** Norditropin®

## Key facts

- **NCT ID:** NCT03878446
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-04
- **Primary completion:** 2021-05-05
- **Final completion:** 2026-12-23
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03878446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03878446, "A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03878446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*